Brian M. Fox

1.3k total citations
10 papers, 516 citations indexed

About

Brian M. Fox is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Brian M. Fox has authored 10 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Brian M. Fox's work include Cancer therapeutics and mechanisms (4 papers), Synthesis and bioactivity of alkaloids (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Brian M. Fox is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Synthesis and bioactivity of alkaloids (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Brian M. Fox collaborates with scholars based in United States, Germany and United Kingdom. Brian M. Fox's co-authors include Mark Cushman, Yves Pommier, Glenda Kohlhagen, Muthusamy Jayaraman, Jeffrey A. Vroman, Dirk Strumberg, Melinda G. Hollingshead, Smitha Antony, Lance Stewart and Bart L. Staker and has published in prestigious journals such as Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Brian M. Fox

10 papers receiving 511 citations

Peers

Brian M. Fox

TOXIC

ONCOL

Hea‐Young Park Choo South Korea

Ehab M. Gedawy Egypt

Chia-Ning Yang Taiwan

Eileen C. Southwick United States

Xiaokang Ge United States

Eileen Brantley United States

Kalpana Tilekar India

Hairuo Peng United States

Xiao‐Hui Gu China

Melissa S. Bentle United States

Hea‐Young Park Choo South Korea

Brian M. Fox

231 ×0.7

270 ×1.0

52 ×0.5

TOXIC

39 ×0.5

70 ×1.1

ONCOL

Citations per year, relative to Brian M. Fox Brian M. Fox (= 1×) peers Hea‐Young Park Choo

Countries citing papers authored by Brian M. Fox

Since Specialization

Citations

This map shows the geographic impact of Brian M. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Fox more than expected).

Fields of papers citing papers by Brian M. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Fox. The network helps show where Brian M. Fox may publish in the future.

Co-authorship network of co-authors of Brian M. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Fox. A scholar is included among the top collaborators of Brian M. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Fox. Brian M. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Fox, Brian M., Hilary P. Beck, Philip M. Roveto, et al.. (2015). A Selective Prostaglandin E₂ Receptor Subtype 2 (EP2) Antagonist Increases the Macrophage-Mediated Clearance of Amyloid-Beta Plaques. Journal of Medicinal Chemistry. 58(13). 5256–5273. 50 indexed citations

Fox, Brian M., Reina Natero, Richard Connors, et al.. (2011). Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition. Bioorganic & Medicinal Chemistry Letters. 21(8). 2460–2467. 13 indexed citations

Fox, Brian M., Kiyosei Iio, Kexue Li, et al.. (2010). Discovery of pyrrolopyridazines as novel DGAT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(20). 6030–6033. 23 indexed citations

Beck, Hilary P., Brian M. Fox, John G. Allen, et al.. (2010). Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(9). 2752–2755. 29 indexed citations

Connors, Richard, Zhulun Wang, Martin Harrison, et al.. (2009). Identification of a PPARδ agonist with partial agonistic activity on PPARγ. Bioorganic & Medicinal Chemistry Letters. 19(13). 3550–3554. 33 indexed citations

Morrell, Andrew, Muthusamy Jayaraman, Muthukaman Nagarajan, et al.. (2006). Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay. Bioorganic & Medicinal Chemistry Letters. 16(16). 4395–4399. 15 indexed citations

Fox, Brian M., Xiangshu Xiao, Smitha Antony, et al.. (2003). Design, Synthesis, and Biological Evaluation of Cytotoxic 11-Alkenylindenoisoquinoline Topoisomerase I Inhibitors and Indenoisoquinoline−Camptothecin Hybrids. Journal of Medicinal Chemistry. 46(15). 3275–3282. 86 indexed citations

Jayaraman, Muthusamy, Brian M. Fox, Melinda G. Hollingshead, et al.. (2001). Synthesis of New Dihydroindeno[1,2-c]isoquinoline and Indenoisoquinolinium Chloride Topoisomerase I Inhibitors Having High in Vivo Anticancer Activity in the Hollow Fiber Animal Model. Journal of Medicinal Chemistry. 45(1). 242–249. 88 indexed citations

Fox, Brian M., Jeffrey A. Vroman, Phillip E. Fanwick, & Mark Cushman. (2001). Preparation and Evaluation of Sulfide Derivatives of the Antibiotic Brefeldin A as Potential Prodrug Candidates with Enhanced Aqueous Solubilities. Journal of Medicinal Chemistry. 44(23). 3915–3924. 33 indexed citations

10.

Cushman, Mark, Muthusamy Jayaraman, Jeffrey A. Vroman, et al.. (2000). Synthesis of New Indeno[1,2-c]isoquinolines: Cytotoxic Non-Camptothecin Topoisomerase I Inhibitors. Journal of Medicinal Chemistry. 43(20). 3688–3698. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact